2024 Year In Review: BioTalk Unzipped
BioTalk Unzipped17 Maalis 2025

2024 Year In Review: BioTalk Unzipped

In this episode of BioTalk Unzipped, hosts Gregory Austin and Dr. Chad Briscoe reflect on their journey over the past year, discussing key themes and insights gained from their guests. They explore the humanistic approach to healthcare, the impact of AI in drug development, common threads among successful individuals, personal growth through conversations, and the importance of leadership and mentorship in the industry. The episode concludes with exciting plans for future series focused on drug development and global healthcare innovations.

Thanks to CREO Consulting for hosting this episode!

https://creoconsulting.com/


Dr. Chad Briscoe

https://www.linkedin.com/in/chadbriscoe/

Celerion - https://www.celerion.com/


Gregory Austin

https://www.linkedin.com/in/gregoryaustin1/

Celerion - https://www.celerion.com/


Takeaways

  • Every sample is a person, a patient, a loved one.
  • Embrace the fear, take more risks.
  • The importance of human connection in drug development.
  • AI is becoming integral in drug discovery and development.
  • Successful individuals often wish they had taken more risks.
  • Leadership in the industry is about raising others up.
  • Mentorship plays a crucial role in professional growth.
  • Personal growth can come from listening and engaging with others.
  • Innovative approaches are essential in addressing industry challenges.


Keywords

BioTalk, drug development, AI, mentorship, leadership, podcast, healthcare, innovation, personal growth, industry insights

Jaksot(41)

How AI is Helping Diagnose Disease with Chuck Piccirillo

How AI is Helping Diagnose Disease with Chuck Piccirillo

Summary In this conversation, Gregory Austin and Chad Briscoe interview Chuck Piccirillo, CEO of Zealic Health, about his experience in the healthcare industry and the focus on patient-centric soluti...

2 Elo 202438min

Reptiles, Treatments, and Cell-Gene Therapy with Dr. Vick

Reptiles, Treatments, and Cell-Gene Therapy with Dr. Vick

Summary Dr. Andy Vick shares some of the things that surprised him throughout his career and he discusses his passion for reptiles and his experience discussing the pharmaceutical potential of venom w...

15 Heinä 202438min

Amyloidosis Exposed: New Hope with Dr. Vick

Amyloidosis Exposed: New Hope with Dr. Vick

Summary Dr. Andy Vick discusses his work at Attralus Therapeutics, a biotech company focused on developing treatments for systemic amyloidosis. He explains the etiology of the disease and how Attralus...

1 Heinä 202440min

A Diagnostic Breakthrough for Alzheimer’s with Dr. Jonathon Hill

A Diagnostic Breakthrough for Alzheimer’s with Dr. Jonathon Hill

A Diagnostic Breakthrough for Alzheimer’s Summary In this conversation, Dr. Jonathan Hill discusses his work in nanopore sequencing-based technology and its applications in genetic and epigenetic rese...

1 Kesä 202430min

The AI Prescription: Revolutionizing Pharma & Patient Care with Jason Burke

The AI Prescription: Revolutionizing Pharma & Patient Care with Jason Burke

The AI Prescription: Revolutionizing Pharma & Patient Care with Jason Burke Summary In Episode 13, Jason Burke discusses the unique approach of the Duke program in providing real-world healthcare data...

15 Touko 202435min

Unlocking the Future of Healthcare with Organoids, AI, and Quantum Computing with Jason Burke

Unlocking the Future of Healthcare with Organoids, AI, and Quantum Computing with Jason Burke

Summary In this episode of BioTalk Unzipped, the hosts discuss the applications and ethical concerns surrounding organoids, which are 3D cell clusters that mimic the features of full-sized organs. The...

1 Touko 202434min

Breakthrough in Melanoma, Rare Diseases, and Curative Therapies with Scott Schliebner

Breakthrough in Melanoma, Rare Diseases, and Curative Therapies with Scott Schliebner

Summary In this episode, Scott Schliebner discusses the unique challenges and complexities of rare disease trials. He highlights the difficulties in recruiting patients, the multidisciplinary nature o...

15 Huhti 202436min

Impact of AI in Rare Disease Trials with Scott Schliebner

Impact of AI in Rare Disease Trials with Scott Schliebner

Impact of AI in Rare Disease Trials with Scott Schliebner Summary In this episode, the hosts welcome Scott Schliebner as their guest and kick off with a charitable act, donating to Rare Givers. They d...

1 Huhti 202436min

Suosittua kategoriassa Liike-elämä ja talous

sijotuskasti
mimmit-sijoittaa
rss-rahapodi
psykopodiaa-podcast
herrasmieshakkerit
rss-lahtijat
leadcast
rahapuhetta
rss-seuraava-potilas
ostan-asuntoja-podcast
inderespodi
rss-rahamania
rss-porssipuhetta
rss-laakispodi
rss-vaikuttavan-opettajan-vierella
rss-karon-grilli
rss-juurisyy-johtamisesta-kilpailuetua
rss-40-ajatusta-aanesta
rss-porssipodi
rss-johtoajatuksia